Oui, les groupes de soutien offrent un environnement d'encouragement et de partage d'expériences.
Groupes de soutienIntervention sociale
#5
Combien de temps dure un traitement pour le tabagisme ?
La durée du traitement varie, mais il est souvent recommandé de suivre un programme de plusieurs mois.
Durée du traitementPlan de traitement
Complications
5
#1
Quelles sont les complications du tabagisme ?
Les complications incluent des maladies cardiovasculaires, des cancers et des maladies respiratoires.
Maladies cardiovasculairesCancers
#2
Le tabagisme affecte-t-il la santé mentale ?
Oui, il est associé à des troubles de l'humeur, de l'anxiété et des problèmes de dépendance.
Santé mentaleTroubles de l'humeur
#3
Le tabagisme peut-il entraîner des problèmes de fertilité ?
Oui, il peut réduire la fertilité chez les hommes et les femmes, affectant la reproduction.
FertilitéSanté reproductive
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être réversibles avec l'arrêt du tabac, mais pas toutes.
RéversibilitéArrêt du tabac
#5
Le tabagisme augmente-t-il le risque d'infections ?
Oui, il affaiblit le système immunitaire, augmentant le risque d'infections respiratoires.
Infections respiratoiresSystème immunitaire
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du tabagisme ?
Les facteurs incluent l'exposition à la fumée, l'hérédité et des influences sociales.
Facteurs de risqueExposition à la fumée
#2
L'âge influence-t-il le risque de tabagisme ?
Oui, les jeunes adultes sont plus susceptibles de commencer à fumer en raison de la pression sociale.
ÂgePression sociale
#3
Le stress est-il un facteur de risque ?
Oui, le stress peut inciter à fumer comme moyen de gestion des émotions et de l'anxiété.
StressGestion des émotions
#4
Les antécédents familiaux jouent-ils un rôle ?
Oui, avoir des membres de la famille fumeurs augmente le risque de développer une dépendance.
Antécédents familiauxDépendance au tabac
#5
Les publicités influencent-elles le tabagisme ?
Oui, les publicités peuvent normaliser le tabagisme et inciter les jeunes à commencer à fumer.
PublicitéInfluence sociale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Trouble lié au tabagisme : Questions médicales les plus fréquentes",
"headline": "Trouble lié au tabagisme : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Trouble lié au tabagisme : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-31",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Trouble lié au tabagisme"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles liés à une substance",
"url": "https://questionsmedicales.fr/mesh/D019966",
"about": {
"@type": "MedicalCondition",
"name": "Troubles liés à une substance",
"code": {
"@type": "MedicalCode",
"code": "D019966",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Trouble lié au tabagisme",
"alternateName": "Tobacco Use Disorder",
"code": {
"@type": "MedicalCode",
"code": "D014029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joseph Guydish",
"url": "https://questionsmedicales.fr/author/Joseph%20Guydish",
"affiliation": {
"@type": "Organization",
"name": "Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: joseph.guydish@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Thao Le",
"url": "https://questionsmedicales.fr/author/Thao%20Le",
"affiliation": {
"@type": "Organization",
"name": "Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: thao.le@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Kevin Delucchi",
"url": "https://questionsmedicales.fr/author/Kevin%20Delucchi",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, University of California San Francisco, 401 Parnassus Ave., San Francisco, CA 94143, United States of America. Electronic address: kevin.delucchi@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Guang-Heng Dong",
"url": "https://questionsmedicales.fr/author/Guang-Heng%20Dong",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Yunnan Normal University, Kunming, Yunnan Province, PR China. Electronic address: dongguangheng@ynnu.edu.cn."
}
},
{
"@type": "Person",
"name": "Caravella McCuistian",
"url": "https://questionsmedicales.fr/author/Caravella%20McCuistian",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry and Behavioral Sciences, University of California, San Francisco 1001 Potrero Ave, San Francisco, CA 94110, United States. Electronic address: caravella.mccuistian@ucsf.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Nutrition for Cancer Survivors.",
"datePublished": "2022-10-01",
"url": "https://questionsmedicales.fr/article/36235745",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu14194093"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hypertension in Cancer Survivors.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35852781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11906-022-01208-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Survival of cancer survivors with a new pancreatic cancer diagnosis.",
"datePublished": "2022-06-08",
"url": "https://questionsmedicales.fr/article/35674139",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.4903"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep disturbances among cancer survivors.",
"datePublished": "2023-10-12",
"url": "https://questionsmedicales.fr/article/37837808",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.canep.2023.102471"
}
},
{
"@type": "ScholarlyArticle",
"name": "Psychological and sexual problems of cancer survivors.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37254933",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4081/aiua.2023.11473"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles liés à une substance",
"item": "https://questionsmedicales.fr/mesh/D019966"
},
{
"@type": "ListItem",
"position": 4,
"name": "Trouble lié au tabagisme",
"item": "https://questionsmedicales.fr/mesh/D014029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Trouble lié au tabagisme - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Trouble lié au tabagisme",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Trouble lié au tabagisme",
"description": "Comment diagnostiquer un trouble lié au tabagisme ?\nQuels critères sont utilisés pour le diagnostic ?\nQui peut poser le diagnostic ?\nY a-t-il des tests spécifiques pour le diagnostic ?\nLe diagnostic peut-il être fait à distance ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Cancer+Survivors#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Trouble lié au tabagisme",
"description": "Quels sont les symptômes du trouble lié au tabagisme ?\nComment se manifeste le sevrage tabagique ?\nLe tabagisme peut-il affecter l'humeur ?\nY a-t-il des symptômes physiques associés ?\nLes symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Cancer+Survivors#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Trouble lié au tabagisme",
"description": "Comment prévenir le trouble lié au tabagisme ?\nLes campagnes anti-tabac sont-elles efficaces ?\nQuel rôle jouent les écoles dans la prévention ?\nLes lois anti-tabac aident-elles à réduire la consommation ?\nLes programmes de cessation sont-ils accessibles ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Cancer+Survivors#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Trouble lié au tabagisme",
"description": "Quels traitements sont disponibles pour le tabagisme ?\nLes médicaments sont-ils efficaces contre le tabagisme ?\nQu'est-ce que la thérapie comportementale ?\nLes groupes de soutien sont-ils utiles ?\nCombien de temps dure un traitement pour le tabagisme ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Cancer+Survivors#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Trouble lié au tabagisme",
"description": "Quelles sont les complications du tabagisme ?\nLe tabagisme affecte-t-il la santé mentale ?\nLe tabagisme peut-il entraîner des problèmes de fertilité ?\nLes complications sont-elles réversibles ?\nLe tabagisme augmente-t-il le risque d'infections ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Cancer+Survivors#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Trouble lié au tabagisme",
"description": "Quels sont les principaux facteurs de risque du tabagisme ?\nL'âge influence-t-il le risque de tabagisme ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes publicités influencent-elles le tabagisme ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Cancer+Survivors#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble lié au tabagisme ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de dépendance."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la consommation régulière, le désir de réduire et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Qui peut poser le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel de santé, comme un médecin ou un psychologue, peut poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests spécifiques pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de tests spécifiques, le diagnostic est basé sur l'entretien clinique."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il être fait à distance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations en ligne peuvent permettre d'évaluer les habitudes de consommation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du trouble lié au tabagisme ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent le besoin urgent de fumer, l'irritabilité et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le sevrage tabagique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sevrage peut provoquer anxiété, dépression, troubles du sommeil et fringales."
}
},
{
"@type": "Question",
"name": "Le tabagisme peut-il affecter l'humeur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut entraîner des fluctuations d'humeur et des troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la toux, l'essoufflement et des douleurs thoraciques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la durée et de l'intensité de la consommation."
}
},
{
"@type": "Question",
"name": "Comment prévenir le trouble lié au tabagisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, la sensibilisation et des politiques anti-tabac efficaces."
}
},
{
"@type": "Question",
"name": "Les campagnes anti-tabac sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sensibilisent le public aux dangers du tabagisme et encouragent l'arrêt."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les écoles dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les écoles peuvent éduquer les jeunes sur les dangers du tabac et promouvoir des modes de vie sains."
}
},
{
"@type": "Question",
"name": "Les lois anti-tabac aident-elles à réduire la consommation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lois strictes sur la vente et la consommation de tabac réduisent son usage."
}
},
{
"@type": "Question",
"name": "Les programmes de cessation sont-ils accessibles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux programmes de cessation sont disponibles dans les centres de santé et en ligne."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le tabagisme ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils efficaces contre le tabagisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme la varénicline et le bupropion sont efficaces pour réduire le besoin de fumer."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie comportementale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une approche qui aide à modifier les comportements liés à la consommation de tabac."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un environnement d'encouragement et de partage d'expériences."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement pour le tabagisme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais il est souvent recommandé de suivre un programme de plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du tabagisme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies cardiovasculaires, des cancers et des maladies respiratoires."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est associé à des troubles de l'humeur, de l'anxiété et des problèmes de dépendance."
}
},
{
"@type": "Question",
"name": "Le tabagisme peut-il entraîner des problèmes de fertilité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut réduire la fertilité chez les hommes et les femmes, affectant la reproduction."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec l'arrêt du tabac, mais pas toutes."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque d'infections ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il affaiblit le système immunitaire, augmentant le risque d'infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du tabagisme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à la fumée, l'hérédité et des influences sociales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de tabagisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes sont plus susceptibles de commencer à fumer en raison de la pression sociale."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut inciter à fumer comme moyen de gestion des émotions et de l'anxiété."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des membres de la famille fumeurs augmente le risque de développer une dépendance."
}
},
{
"@type": "Question",
"name": "Les publicités influencent-elles le tabagisme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les publicités peuvent normaliser le tabagisme et inciter les jeunes à commencer à fumer."
}
}
]
}
]
}
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: joseph.guydish@ucsf.edu.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: thao.le@ucsf.edu.
Department of Psychiatry, University of California San Francisco, 401 Parnassus Ave., San Francisco, CA 94143, United States of America. Electronic address: kevin.delucchi@ucsf.edu.
Department of Psychiatry and Behavioral Sciences, University of California, San Francisco 1001 Potrero Ave, San Francisco, CA 94110, United States. Electronic address: caravella.mccuistian@ucsf.edu.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA, 94118, United States. Electronic address: kwinoja.kapiteni@ucsf.edu.
OHSU/PSU School of Public Health, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239-3098, United States. Electronic address: drbarbaracampbell@earthlink.net.
Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan; School of Nursing, University of Michigan, Ann Arbor, Michigan.
Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan; School of Nursing, University of Michigan, Ann Arbor, Michigan; Addiction Center, Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
With increasing survival after cancer treatment, there is a need for long-term management of risk factors and chronic medical conditions to realize the full benefit of improvement of outcomes. Hyperte...
A lot of newer anti-cancer therapies have been implicated in the development or worsening of hypertension. We summarize the latest data, explore associations between these therapies and hypertension, ...
Persons newly diagnosed with pancreas cancer and who have survived a previous cancer are often excluded from clinical trials, despite limited evidence about their prognosis. We examined the associatio...
This US population-based cohort study included older adults (aged ≥66 years) diagnosed with pancreas cancer between 2005 and 2015 in the linked Surveillance, Epidemiology, and End Results-Medicare dat...
Of 32,783 patients, 18.7% were previously diagnosed with another cancer. The most common previous cancers included prostate (29.0%), breast (18.9%), or colorectal (9.7%) cancer. More than half of prev...
Given nearly equivalent survival compared to those without previous cancer, cancer survivors newly diagnosed with pancreas cancer should be considered for inclusion in pancreas cancer clinical trials....
We investigated sleep disturbances among cancer survivors compared to similarly aged women without cancer history....
We identified 2067 women with a history of cancer other than breast or non-melanoma skin cancer at enrollment in the Sister Study, a US-wide cohort of women with a family history of breast cancer. Can...
At enrollment, cancer survivors were on average 13.8 years (range=0, 62) from diagnosis. After adjustment for age at enrollment and depression, diabetes, hypertension, and menopausal status prior to t...
Addressing sleep disturbances may improve well-being for cancer survivors....
To explore: 1) the unmet needs of breast cancer patients; 2) the sexual needs experienced by breast cancer survivors; 3) the experiences of cancer patients at the time of relapse, including the biopsy...
Interpretative phenomenological qualitative research by conducting direct in-depth interviews with participants who met the inclusion criteria. Sample analyzed were breast cancer survivors who had exp...
Themes identified for breast cancer patients with unmet needs were i) overcoming health problems in breast cancer survivors; ii) need to access the best health services; iii) women's unmet information...
Health-related problems of breast cancer survivors, such as fatigue and fear of cancer recurrence, can lead them to have trouble with social relationships, question their spirituality, and struggle wi...
This research aims to systematically review a comprehensive sample of websites (English-language) that provide information on nutrition after cancer treatment....
In consultation with cancer survivors and experts, we developed search strings for an internet search (incognito mode in Google Chrome) to be completed in six English-speaking countries (Ireland, the ...
Initially, 720 links were found, with 159 eligible for inclusion. Those eligible for review were charity/support/non-governmental organisation weblinks (49.1%) that originated in the United States (42...
Cancer survivors seeking nutrition information online may encounter difficulty locating advice, and where they do, it is unlikely to contain guidance on implementation into day-to-day life. This is co...
Breast cancer patients commonly present to their OBGYN during the process of diagnosis and treatment of breast cancer both for specific gynecologic needs and for primary care follow up. These patients...
Fear of cancer recurrence is common among survivors of adult-onset cancer and associated with increased distress, functional impairment, and health care utilization. However, little is known about the...
To characterize the prevalence of and risk factors for clinically significant fear of cancer recurrence in adult survivors of childhood cancer....
This cross-sectional investigation included participants recruited from the Childhood Cancer Survivor Study, a retrospective cohort study of long-term childhood cancer survivors treated at 31 institut...
Clinically significant fear of cancer recurrence was assessed via the Fear of Cancer Recurrence Inventory-Short Form. Poisson regression models estimated prevalence ratios (PRs) with 95% CIs adjusted ...
The final sample included 229 adult survivors of childhood cancer (115 female [50.2%]; mean [SD] age, 39.6 [9.9] years; mean [SD] time since diagnosis, 31.7 [8.4] years). Among survivors, 38 (16.6%; 9...
Decades following treatment, one-third of childhood cancer survivors in this study reported elevated fear their cancer will recur or a subsequent malignant neoplasm will develop. Findings suggest that...
Financial burden and distress are high in patients with thyroid cancer. However, little has been done to evaluate potential interventions to mitigate financial toxicity in survivors. This review will ...
Thyroid cancer incidence has nearly tripled in the past decades, and cost of treatment is predicted to rise more than other cancers over the next decade. With mean age of diagnosis at 51 years, most p...
Thyroid cancer survivors have high rates of financial toxicity, and there remains need for longitudinal studies to evaluate how financial burden may change during the treatment process while also asse...
Little is known about cancer survivors' needs in Alaska. To address this knowledge gap, the Alaska Cancer Partnership conducted a needs assessment survey; our objectives were to identify unmet needs o...
Cancer survivors were identified using data from the Alaska Cancer Registry. A random sample of 2,600 individuals was selected to receive the survey, which assessed unmet needs across the following do...
We received 335 survey responses, for a response of 13.7%. Only 29.9% of cancer survivors expressed that all their needs were met. The most highly ranked unmet needs were as follows: help to reduce st...
This assessment provided some of the first information regarding the needs of Alaska's cancer survivors. These results will be used by Alaska Cancer Partnership members across the state to inform heal...